LIVE DAY 1 ✦ September 18 - CST/CDT (Central Daylight, GMT-5)
LIVE DAY 1 ✦ September 18 - CST/CDT (Central Daylight, GMT-5)
- Miree Lee, MS, MBA - Bio/Pharma Pricing, Contracts & Compliance Consultant, M.Lee Consulting LLC
- Doan Finch - Director, Government Pricing & Contracting, Genmab US, Inc.
- Kingshuk Das - Executive Director, Government Programs, Contracts and Customer Administration, Sandoz
- Miree Lee, MS, MBA - Bio/Pharma Pricing, Contracts & Compliance Consultant, M.Lee Consulting LLC
- Josephine Hawkins - Associate Director, Medicaid, AstraZeneca
- Miree Lee, MS, MBA - Bio/Pharma Pricing, Contracts & Compliance Consultant, M.Lee Consulting LLC
- Paula Martins - Director, Government Pricing & Contract Operations, Eisai Inc
- Will Harrison - Principal Product Manager, Chronicled
Most Manufacturers put together their Federal Supply Schedule agreement every 5 – 10 years. Are you getting ready to do yours? Join this session to make sure you’re filling out the appropriate forms and filing within the required deadlines with our expert speakers.
- Chuck Graham - Federal Contracts & Government Strategy Manager, Genentech
- Diana D. Lawal - Chief of Contracting Branch, Pharmacy & Dental Division Team B, U.S. Department of Veterans Affairs
- Trevor Martin, CPCM - Chief, Contract Division Pharm/Dental A, U.S. Department of Veterans Affairs
- Allison Pugsley - Partner, Hogan Lovells US LLP
- Jennifer Plitsch - Partner, Covington & Burling
- Update on government changes to access and renew SAM certification
- Recent hacking of the system and possible downstream effects
- Allison Pugsley - Partner, Hogan Lovells US LLP
- Chuck Graham - Federal Contracts & Government Strategy Manager, Genentech
- Chuck Graham - Federal Contracts & Government Strategy Manager, Genentech
- Ted Karnezis, RPh - Principal Owner, Karnezis Consulting
- Diane Weisbrod - GM, Market Access Contract Performance Solutions, Iqvia
- Luke Greenwalt - Vice President Market Access Center of Excellence Lead, IQVIA
- Pricing product profitability through GTN and how to make accurate assumptions
- PBM Landscape and Contracting Strategies on Structuring Price Protection
- Consider WAC and GTN increase, escalator clause, and anticipate your AMP
- Nick Olivares - Controller, Lundbeck
- Chris Moysey - Associate Principal, US Market Access GTN Solutions, IQVIA
- Felecia Manning - Director, Managed Markets Contracts & Government Pricing, United Therapeutics Corporation
- Matt Champion - Associate Director, US Market Access GTN Solutions COE, IQVIA
Including pitfalls to avoid
- John Lewis - Senior Director, US Market Access GTN Solutions COE, IQVIA
The Town Hall features an open dialogue between Manufacturers and States and may cover topic areas such as:
• Data Integrity
• CLD Analysis
• 340B Disputes
• Historical and aged disputes
• Addressing long wait time for dispute resolution in third-party managed states and how to enhance this process
• Rebate credits
• Discrepancies with URA calculations
• Utilization on supplemental invoices while disputing the same on a federal invoice
- Nicolette Dione, PharmD - Drug Rebate Services Manager, Gainwell Technologies
- Jodi Hettinga - Drug Rebate Specialist, Senior Professional Business Process Outsourcing, Pharmacy Benefit Management, Gainwell Technologies
- Joe DeLuca - Senior Manager, CSL Behring
- Cathy Burton-Meza - Associate Director, Government Rebates, Gilead Sciences
- Jorge Lopez - Associate Director of Government Pricing, Hikma
- Miree Lee, MS, MBA - Bio/Pharma Pricing, Contracts & Compliance Consultant, M.Lee Consulting LLC
- Gourab Khan - Director of Government Pricing and Contracting, Kyowa Kirin
- Jorge Lopez - Associate Director of Government Pricing, Hikma
- Elizabeth Wicyk-McGovern - Senior Manager Pricing & Reimbursement, Pfizer
- Paula Martins - Director, Government Pricing & Contract Operations, Eisai Inc
Back by Popular Demand!
Join us for this deep dive workshop into the ever-changing active and pending SPTR laws from the legal and operational perspectives. Topics discussed will include:
Soup to Nuts requirements (where to go, what to do for new products etc.)
New waiver/changes/updates to TN, OR and more
Examples of reasonable assumptions – differences in terms and definitions across States
Best Practices panel with Manufacturer’s, Counsel and Consultants
Q&A
- Gregg Kasten - VP, Products and Services, ClassOne Insight
- Trevor Wear - Partner, Sidley Austin LLP
SPTR is a complex and dynamic domain, and every pharma manufacturer needs to comply with many state requirements. This session will review results and insights from an industry benchmarking survey of SPTR experiences at over 100 pharma manufacturers.
• Learn how your peers are addressing SPTR management,operations, and compliance
• Gain more understanding of best practices that you can apply inyour organization
• Hear perspectives on future developments
- John McGrory - CEO, ClassOne Insight
SPTR is a complex and dynamic domain, and every pharma manufacturer needs to comply with many state requirements.
• How to manage each individual state and retain accuracy of the data
• Best practices in managing the U.S. territories vs. U.S. current process for states
• The future of PDABS — What manufacturers should expect when they launch
• State intention behind collecting data and intended use (fines, additional discounts, political optics) and how the bottom line may be impacted
- Chris Weiser - Senior Corporate Counsel, US Market Access Legal, Sanofi
- Tiffany Frankson - Assistant General Counsel, Pricing and Access, Pfizer
This session describes core 340B compliance requirements for pharmaceutical manufacturers. Objectives:
- Discuss elements of the pharmaceutical pricing agreement
- Describe 340B ceiling price calculation
- Identify pricing responsibilities with HRSA and wholesalers
- Chris Hatwig, MS, RPh, FASHP - President, Apexus
- Cathy Gilgore, MBA - Associate Principal, Manufacturer Refund Service, Apexus
- Marcy Imada - Managing Director, Deloitte & Touche LLP
- Mitesh Ghia - Director, Institutional Contracts, Chargebacks & Rebates, Novartis Pharmaceuticals Corporations
- Lisa Scholz, PharmD, MBA, FACHE - Vice President, 340B Enterprise Strategy, Health System and Government Services, AmerisourceBergen
This session reviews leading practices for maintaining program integrity and going through the HRSA audit process. Objectives:
- Outline HRSA integrity initiatives
- Discuss leading practices to prepare and complete the HRSA audit process for manufacturers
- Describe post-audit procedures, including implementation of a successful corrective action plan
- Chad Johnson, PharmD, MBA, 340B ACE - Director, 340B Policy and Compliance, Apexus
- Jennifer Lospinoso - Managing Director & Consulting Lead, Riparian
- Christopher Schott - Partner, Latham & Watkins
- Chuck Stubbs, PharmD, MBA, 340B ACE - 340B Drug Pricing Program - Pharmacist, Intermountain Healthcare
Objectives
- Describe common 340B drug dispensing pathways in outpatient settings
- Discuss covered entity inventory management models and purchasing account setups
- Examine differences between good-faith inquiries, HRSA-approved manufacturer audits of covered entities, and covered entity self-audits
- Gavin Magaha, PharmD, MS, 340B ACE - Director, 340B Policy and Compliance, Apexus
- Fern Paul-Aviles, PharmD, MS, BCPS - Assistant Vice President, Atrium Health
- Lisa Nelson, PharmD, RPh, 340B ACE - Pharmacy Director, Unity Care Northwest
- Cathy Burton-Meza - Associate Director, Government Rebates, Gilead Sciences
This session describes the role of the 340B Prime Vendor Program, managed by Apexus, and resources provided to manufacturers. Objectives:
- Identify resources the Prime Vendor provides to support manufacturers and the 340B community
- Discuss contracting and other services available to manufacturers
- Broderick Olson - Director, Contract Services, Pharmacy, Apexus
- Althea Danzey - Director, Pricing and Contract Operations, Merz Therapeutics
- Joseph Favatella, PharmD, MBA, CSP - Chief Administrative Officer, Specialty Pharmacy, Hospital of the University of Pennsylvania
- Lisa Scholz, PharmD, MBA, FACHE - Vice President, 340B Enterprise Strategy, Health System and Government Services, AmerisourceBergen
These one-on-one meetings are scheduled between manufacturers and States to discuss any issues or questions that have come up with rebates and reporting, etc.
•Alaska • Arizona • Arkansas • California • Colorado • Connecticut • DC • Delaware • Georgia • Hawaii •Idaho • Indiana • Kentucky • Louisiana • Maryland • Massachusetts •Michigan • Montana • Nebraska • New Hampshire • New Mexico •New York • North Carolina • Pennsylvania • Rhode Island • South Carolina • Tennessee • Texas •Virginia
- Nicolette Dione, PharmD - Drug Rebate Services Manager, Gainwell Technologies
- Dorine Rascoe - Division Chief, Drug Rebates and Lockbox Services, Office of Finance, Medical Care Programs, Maryland Department of Health
- Jeanine Lundeberg - Director, Pharmacy Rebate Management, Magellan Health
- Dena Karels - CPhT Lead, Manager, Rebate Dispute Management, Magellan Health
- Jodi Hettinga - Drug Rebate Specialist, Senior Professional Business Process Outsourcing, Pharmacy Benefit Management, Gainwell Technologies
- Tykeisha Corbett - Rebate Analyst, Maryland Department of Health
- Steve Smith - Director, Industry Relations, Optum
- Eric Wilcher - Rebate Accountant, Optum
- Pam Williams - Sr. Rebate Analyst, Optum
- Michael Chien, PharmD - Associate Director, Industry Relations, Optum
- Antoine Nelson - Director, Pharmaceutical Rebate Operations, Government Healthcare Solutions, Conduent
- Linh Le - Chief of Drug Rebate, California Department of Health Care Services
- Erh-hsin Ling - Drug Rebate Unit Chief, California Department of Health Care Services
These one-on-one meetings are scheduled between manufacturers and States to discuss any issues or questions that have come up with rebates and reporting, etc.
•Alaska • Arizona • Arkansas • California • Colorado • Connecticut • DC • Delaware • Georgia • Hawaii •Idaho • Indiana • Kentucky • Louisiana • Maryland • Massachusetts •Michigan • Montana • Nebraska • New Hampshire • New Mexico •New York • North Carolina • Pennsylvania • Rhode Island • South Carolina • Tennessee • Texas •Virginia
- Nicolette Dione, PharmD - Drug Rebate Services Manager, Gainwell Technologies
- Dorine Rascoe - Division Chief, Drug Rebates and Lockbox Services, Office of Finance, Medical Care Programs, Maryland Department of Health
- Jeanine Lundeberg - Director, Pharmacy Rebate Management, Magellan Health
- Dena Karels - CPhT Lead, Manager, Rebate Dispute Management, Magellan Health
- Jodi Hettinga - Drug Rebate Specialist, Senior Professional Business Process Outsourcing, Pharmacy Benefit Management, Gainwell Technologies
- Tykeisha Corbett - Rebate Analyst, Maryland Department of Health
- Steve Smith - Director, Industry Relations, Optum
- Eric Wilcher - Rebate Accountant, Optum
- Pam Williams - Sr. Rebate Analyst, Optum
- Michael Chien, PharmD - Associate Director, Industry Relations, Optum
- Antoine Nelson - Director, Pharmaceutical Rebate Operations, Government Healthcare Solutions, Conduent
- Linh Le - Chief of Drug Rebate, California Department of Health Care Services
- Erh-hsin Ling - Drug Rebate Unit Chief, California Department of Health Care Services